Source milbemycin oxime praziquantel dewormer tablet for Dogs Cats Endoparasites

Strategic Sourcing Guide for Milbemycin Oxime and Praziquantel Dewormer Tablets

The global veterinary pharmaceutical market continues to demand robust solutions for parasite control, with the combination of Milbemycin Oxime and Praziquantel standing out as a critical formulation for comprehensive deworming. This specific active ingredient pairing addresses a broad spectrum of endoparasites, making it a high-priority item for veterinary clinics, pet care distributors, and large-scale animal husbandry operations. Sourcing these tablets requires a disciplined approach that balances technical efficacy with rigorous supply chain verification. Buyers must navigate a complex landscape of chemical synthetic drugs where product attributes, such as the specific ratio of active ingredients and the physical form of the tablet, directly influence procurement outcomes. This guide outlines the essential factors for evaluating suppliers and products in this category, ensuring that the final acquisition meets both regulatory standards and operational needs.

Technical Specifications and Formulation Analysis

Understanding the precise technical specifications of Milbemycin Oxime and Praziquantel tablets is the first step in any sourcing strategy. The product is classified under chemical synthetic drugs and is designed specifically for the removal of Ascaris, Hookworm, Whipworm, and Tapeworm. The efficacy of the medication relies heavily on the correct dosage and the stability of the active compounds. In the current market, variations in product models exist, with specific standard formulations observed at 14mg, 56mg, 27.5mg, and 137.5mg. These numerical values represent the concentration of the active ingredients per unit, which must align with the weight and species of the animal being treated.

The physical characteristics of the tablet are equally important for administration and compliance. The product typically appears as a light yellow, oval, scored tablet, which facilitates accurate splitting if dosage adjustments are required for smaller animals. The shape is often described as granulate, and the dosage form is strictly a tablet intended for oral administration. Buyers should verify that the supplier provides products with a clear "prod_model" designation, such as C-MBJ or C-PQT, to ensure traceability. Furthermore, the packaging specifications vary significantly; some units are sold in sets of three pieces, while others are packed in boxes of twelve, with bulk cartons containing up to one hundred boxes. This variation impacts inventory management and logistics planning.

Compliance, Certification, and Regulatory Standards

When sourcing veterinary pharmaceuticals, compliance is non-negotiable. The products listed in this category are designated as "The First Class" in terms of their regulatory standing, implying a high level of quality control. However, buyers must not assume that all listed products automatically meet every international standard without verification. The origin of the products varies, with some listings indicating "Rpc" and others specifying "Shandong (Province)" or "China" as the production location. This geographic diversity necessitates a thorough check of the local regulatory environment and export certifications.

Buyers should explicitly request documentation regarding the "prod_standard" for each batch. The observed standards include specific milligram measurements (e.g., 14mg/56mg), which serve as a baseline for quality assurance. It is critical to verify that the manufacturer holds valid licenses for the production of chemical synthetic drugs. Additionally, the "Pharmacodynamic Influential Factors" must be considered; these include combined medication interactions, incompatibility issues, and animal species sensitivity. A compliant supplier will provide data demonstrating that their product accounts for these factors, ensuring that the medication does not cause adverse reactions when used with other drugs or in specific animal breeds. The shelf life is a key compliance metric, with observed periods ranging from two to three years. Buyers must ensure that the remaining shelf life upon delivery meets their distribution requirements, as expired veterinary drugs pose significant legal and health risks.

Cost Drivers and Pricing Structures

The pricing for Milbemycin Oxime and Praziquantel tablets is influenced by several dynamic factors, resulting in a wide observed range from $0.10 to $8,600. This broad spectrum reflects differences in order volume, packaging configuration, and the specific formulation strength. The minimum order quantity (MOQ) is a primary cost driver, with observed ranges spanning from 1 unit to 100,000 units. For smaller buyers, the high MOQ of 3,000 pieces for certain models may present a barrier, necessitating a negotiation strategy or a search for suppliers with more flexible terms.

Customization services are a significant value-add that can influence the final cost. Many suppliers offer customized packaging, logo placement, and even ingredient adjustments. While these services add value, they often come with a premium or a higher MOQ requirement. Buyers should evaluate whether the cost of customization justifies the branding benefits or if standard packaging is more cost-effective for their market. Additionally, the "Sample" support offered by suppliers can impact the initial procurement cost. While samples are often provided for evaluation, the logistics of obtaining these samples and the subsequent bulk order pricing must be calculated together. The "Our Service" attributes, such as the ability to tailor the product, suggest that the final price is not static but rather a function of the specific requirements of the buyer.

Typical Applications and Target Species

The primary application of these tablets is the prevention and treatment of parasite diseases in companion animals. The "Applicable Objects" are clearly defined as dogs and cats, with some specific listings targeting only cats or only dogs. The product is designed to be effective against endoparasites, specifically targeting Ascaris, Hookworm, Whipworm, and Tapeworm. This broad-spectrum capability makes it a versatile tool for veterinary practices and pet owners alike.

The route of administration is strictly oral, which simplifies the delivery process but requires careful consideration of the animal's acceptance of the tablet. The "Appearance" of the light yellow, oval, scored tablet is designed to make administration easier, as the score line allows for dosage adjustment. However, buyers must verify that the specific model they are sourcing is suitable for the intended species. For instance, while some products are labeled for "Cats and Dogs," others may be restricted to "Cat" or "Dog" only. The "Pharmacodynamic Influential Factors" also include "Animal Species," indicating that the dosage and efficacy may vary depending on the specific breed or size of the animal. Sourcing guides must emphasize the importance of matching the product model to the specific target population to ensure therapeutic success.

Supplier Evaluation and Verification Protocols

Evaluating suppliers for veterinary pharmaceuticals requires a multi-faceted approach that goes beyond simple price comparison. Buyers should prioritize suppliers who demonstrate transparency in their "prod_origin" and "prod_standard." The presence of a "Sample" support option is a positive indicator of supplier confidence, allowing buyers to test the product before committing to a large order. However, the availability of samples does not guarantee the quality of the bulk shipment, so a rigorous verification process is essential.

Key evaluation criteria should include the supplier's ability to provide detailed technical data sheets, certificates of analysis (COA), and proof of regulatory compliance. The "Storage Condition" and "Storage Method" provided by the supplier, such as "Room Temperature Seal" or "Moisture Proof," must be verified against the buyer's logistics capabilities. If the product requires specific temperature control to maintain its "Shelf Life" of two to three years, the supplier must demonstrate a reliable cold chain or dry storage infrastructure. Furthermore, the "Customization" capabilities should be assessed based on the supplier's track record and the lead times associated with custom orders. Buyers should avoid suppliers who cannot provide clear evidence of their manufacturing standards or who are vague about their production location.

Quality Control and Long-Term Procurement Considerations

Quality control is the backbone of a successful procurement strategy for veterinary drugs. The "Product Name" and "Main Ingredients" must be consistent across all batches to ensure therapeutic reliability. Buyers should implement a quality control protocol that includes random sampling and third-party testing upon receipt of goods. The "Validity Period" of the product, observed at two years for some models and three years for others, must be strictly monitored to prevent the distribution of expired medication.

Long-term procurement considerations involve building a sustainable relationship with suppliers who can guarantee consistent supply and quality. The "Our Service" attributes, such as customized packaging and ingredient adjustments, suggest that suppliers are willing to adapt to market changes. However, buyers must ensure that these customizations do not compromise the core efficacy of the drug. The "Pharmacodynamic Influential Factors," including "Combined Medication" and "Incompatibility," highlight the need for ongoing communication with suppliers regarding any changes in veterinary guidelines or drug interactions. Finally, the "MOQ" of 3,000 pieces for certain models indicates that buyers should plan their inventory carefully to avoid overstocking or stockouts. By maintaining a strategic approach to sourcing, buyers can ensure a steady supply of high-quality Milbemycin Oxime and Praziquantel tablets for their veterinary needs.